Filament's patent describes the extraction of stable, standardized doses of psychoactive compounds at its Health Canada-licensed, GMP-certified facility VANCOUVER, BC, Aug. 3, 2021 /CNW/ - Filament ...

a, Synthesis process of the oligomer. b, Filaments can be drawn by pulling a needle out of an oligomer solution droplet (schematically illustrated in inset). The red arrow connects the droplet to its ...

Expands Red Light's drug development platform with Filament's GMP manufacturing, Health Canada Dealer's Licence, Health Canada and FDA-authorized clinical programs, and 76 issued patents covering ...